Статті в журналах з теми "XP"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "XP".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Cowham, R. "To XP or not to XP?" ITNOW 47, no. 2 (March 1, 2005): 16. http://dx.doi.org/10.1093/itnow/bwi030.
Повний текст джерелаFischer, R., M. Uhl, and H. Vonach. "Nb93(n,xp),Agnat(n,xp), andInnat(n,xp) reactions at 14.1 MeV." Physical Review C 37, no. 2 (February 1, 1988): 578–86. http://dx.doi.org/10.1103/physrevc.37.578.
Повний текст джерелаLitts, Thom, and Jeff Kopaska. "RIP XP." Fisheries 39, no. 4 (April 3, 2014): 151. http://dx.doi.org/10.1080/03632415.2014.893871.
Повний текст джерелаSonia, Archana Singhal, and Hema Banati. "FISA-XP." ACM SIGSOFT Software Engineering Notes 39, no. 3 (June 4, 2014): 1–14. http://dx.doi.org/10.1145/2597716.2597728.
Повний текст джерелаLee, Jeeyun, Do Hoon Lim, Sung Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, et al. "Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial." Journal of Clinical Oncology 30, no. 3 (January 20, 2012): 268–73. http://dx.doi.org/10.1200/jco.2011.39.1953.
Повний текст джерелаIvorra, Wilfrid. "Sur les équations xp+2βyp= z2et xp+2βyp= 2z2". Acta Arithmetica 108, № 4 (2003): 327–38. http://dx.doi.org/10.4064/aa108-4-3.
Повний текст джерелаFassihi, Hiva, Mieran Sethi, Heather Fawcett, Jonathan Wing, Natalie Chandler, Shehla Mohammed, Emma Craythorne, et al. "Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect." Proceedings of the National Academy of Sciences 113, no. 9 (February 16, 2016): E1236—E1245. http://dx.doi.org/10.1073/pnas.1519444113.
Повний текст джерелаKunwar, Sundar. "Enabling and Limiting factors in eXtreme Programming (XP) with Evaluation Framework." SCITECH Nepal 14, no. 1 (September 9, 2019): 50–62. http://dx.doi.org/10.3126/scitech.v14i1.25534.
Повний текст джерелаMaxmen, Amy. "XP mutant power!" Journal of Experimental Medicine 206, no. 13 (November 30, 2009): 2856. http://dx.doi.org/10.1084/jem.20613iti2.
Повний текст джерелаRapićOtrin, Vesna, Isao Kuraoka, Tiziana Nardo, Mary McLenigan, A. P. M. Eker, Miria Stefanini, Arthur S. Levine, and Richard D. Wood. "Relationship of the Xeroderma Pigmentosum Group E DNA Repair Defect to the Chromatin and DNA Binding Proteins UV-DDB and Replication Protein A." Molecular and Cellular Biology 18, no. 6 (June 1, 1998): 3182–90. http://dx.doi.org/10.1128/mcb.18.6.3182.
Повний текст джерелаStanojevic, Jelena. "On estimation of high quantiles for certain classes of distributions." Yugoslav Journal of Operations Research 25, no. 2 (2015): 299–312. http://dx.doi.org/10.2298/yjor130606013s.
Повний текст джерелаSuman, AHM Khairul Imam, Khadija Begum, Kaniz Rahman, Abu Mohammed Talukder, SM Matiur Rahman, Md Akmat Ali, Nusrath Jahan Hoque, and Mohammad Morshad Alam. "Association of Xanthelasma palpebrarum (XP) with cardiovascular disease (CVD) risk factors." Asian Journal of Medical and Biological Research 5, no. 4 (February 3, 2020): 324–29. http://dx.doi.org/10.3329/ajmbr.v5i4.45271.
Повний текст джерелаVaz-Garcia, Eduarda Santiago, Victor Talarico Leal Vieira, Natasha Pereira da Silva Ferreira Petitet, Edson Jorge Lima Moreira, Hélio Pereira Lopes, Carlos Nelson Elias, Emmanuel João Nogueira Leal Silva, and Henrique dos Santos Antunes. "Mechanical Properties of Anatomic Finishing Files: XP-Endo Finisher and XP-Clean." Brazilian Dental Journal 29, no. 2 (March 2018): 208–13. http://dx.doi.org/10.1590/0103-6440201801903.
Повний текст джерелаPrice, Vera H. "Trichothiodystrophy: Current Concepts." Journal of Cutaneous Medicine and Surgery 1, no. 1 (July 1996): 45–49. http://dx.doi.org/10.1177/120347549600100113.
Повний текст джерелаMiao, Junjie, Changchun Chai, Wei Zhang, Yanxing Song, and Yintang Yang. "First-Principles Study on Structural, Mechanical, Anisotropic, Electronic and Thermal Properties of III-Phosphides: XP (X = Al, Ga, or In) in the P6422 Phase." Materials 13, no. 3 (February 4, 2020): 686. http://dx.doi.org/10.3390/ma13030686.
Повний текст джерелаLee, J., W. Kang, D. Lim, J. Park, Y. Park, H. Lim, T. Sohn, J. Noh, J. Bae, and S. Kim. "Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 4537. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.4537.
Повний текст джерелаFernández-Sánchez, Javier. "Against a clausal ellipsis account of all stripping strings in Spanish." Poznan Studies in Contemporary Linguistics 55, no. 1 (March 26, 2018): 53–87. http://dx.doi.org/10.1515/psicl-2019-0003.
Повний текст джерелаRana, MS, MM Rahman, UK Rima, and NS Juyena. "General anaesthesia of indigenous pigs in Bangladesh." Bangladesh Veterinarian 30, no. 2 (March 6, 2014): 46–53. http://dx.doi.org/10.3329/bvet.v30i2.18254.
Повний текст джерелаKarentz, D., and J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, no. 10 (October 1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428.
Повний текст джерелаKarentz, D., and J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, no. 10 (October 1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428-3432.1986.
Повний текст джерелаMartens, M. C., L. Boeckmann, and S. Emmert. "Genetisch bedingte Hauterkrankungen – Xeroderma pigmentosum und das CEDNIK-Syndrom." Aktuelle Dermatologie 46, no. 08/09 (August 20, 2020): 375–78. http://dx.doi.org/10.1055/a-1148-3867.
Повний текст джерелаRothkopf, Michael. "An Algorithmic Approach for Lipid Metabolism and Management of Patients with Xanthelasma Palpebrarum (XP)." Current Developments in Nutrition 4, Supplement_2 (May 29, 2020): 1140. http://dx.doi.org/10.1093/cdn/nzaa055_025.
Повний текст джерелаAlakshar, Asmaa, Abdul Rahman Mohammed Saleh, and Mehmet Omer Gorduysus. "Debris and Smear Layer Removal from Oval Root Canals Comparing XP-Endo Finisher, EndoActivator, and Manual Irrigation: A SEM Evaluation." European Journal of Dentistry 14, no. 04 (August 10, 2020): 626–33. http://dx.doi.org/10.1055/s-0040-1714762.
Повний текст джерелаSugimoto, Naotoshi, Tetsuhiro Yoshinami, Sachiko Yamamoto, Toshinari Yagi, and Fumio Imamura. "Does capecitabine plus cisplatin (XP) give advanced or recurrent gastric cancer (AGC) patients higher early tumor shrinkage (ETS) rate than S1 plus cisplatin (SP) with safety?" Journal of Clinical Oncology 33, no. 3_suppl (January 20, 2015): 172. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.172.
Повний текст джерелаTakeno, Atsushi, Youichi Makari, Shunji Endo, Jin Matsuyama, Ryohei Kawabata, Naotoshi Sugimoto, Hirokazu Taniguchi, et al. "Randomized, open-label, phase II study comparing five-weekly S-1 plus cisplatin (SP) with tri-weekly capecitabine plus cisplatin (XP) in chemotherapy-naïve patients with HER2 negative advanced gastric cancer (AGC): OGSG 1105 HERBIS-4A trial." Journal of Clinical Oncology 36, no. 4_suppl (February 1, 2018): 102. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.102.
Повний текст джерелаBahrudin, Ida Aryanie, Rafizah Mohd Hanifa, Mohd Ezree Abdullah, and Muhammad Firdaus Kamarudin. "Adapting eXtreme Programming Approach in Developing Electronic Document Online System (eDoc)." Applied Mechanics and Materials 321-324 (June 2013): 2938–41. http://dx.doi.org/10.4028/www.scientific.net/amm.321-324.2938.
Повний текст джерелаGengler, Barbara. "XP a National Threat?" Network Security 2001, no. 11 (November 2001): 5. http://dx.doi.org/10.1016/s1353-4858(01)01111-4.
Повний текст джерелаJ.-M.M. "XP Centaur en majesté." Revue Francophone des Laboratoires 2007, no. 388 (January 2007): 10. http://dx.doi.org/10.1016/s1773-035x(07)80003-7.
Повний текст джерелаSchwarz, Diemo, and Etienne Brunet. "theconcatenator: Placard XP edit." Leonardo Music Journal 18 (December 2008): 89–90. http://dx.doi.org/10.1162/lmj.2008.18.89b.
Повний текст джерелаReifer, D. J. "XP and the CMM." IEEE Software 20, no. 3 (May 2003): 14–15. http://dx.doi.org/10.1109/ms.2003.1196314.
Повний текст джерелаTorre, Alberto C. de la. "The ubiquitous XP commutator." European Journal of Physics 27, no. 2 (January 3, 2006): 225–30. http://dx.doi.org/10.1088/0143-0807/27/2/005.
Повний текст джерелаFraser, Steven, and Giancarlo Succi. "XP requirement negotiation workshop." ACM SIGAPP Applied Computing Review 10, no. 1 (April 2002): 26–31. http://dx.doi.org/10.1145/568235.568239.
Повний текст джерелаYu, Jeong Il, Hee Chul Park, Jeeyun Lee, Changhoon Choi, Won Ki Kang, Se Hoon Park, Seung Tae Kim, et al. "Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer." Cancers 12, no. 4 (April 10, 2020): 943. http://dx.doi.org/10.3390/cancers12040943.
Повний текст джерелаPoulin, Yves, Robert Bissonnette, Christina Juneau, Kim Cantin, Rejean Drouin, and Patrice E. Poubelle. "XP-828L in the Treatment of Mild to Moderate Psoriasis: Randomized, Double-Blind, Placebo-Controlled Study." Journal of Cutaneous Medicine and Surgery 10, no. 5 (September 2006): 241–48. http://dx.doi.org/10.2310/7750.2006.00049.
Повний текст джерелаBeroual, Nabil, and Ahmed Bendjeddou. "On a Predator–Prey System with Holling Functional Response: xp/(a + xp)." National Academy Science Letters 39, no. 1 (October 12, 2015): 43–46. http://dx.doi.org/10.1007/s40009-015-0400-6.
Повний текст джерелаYang, Tianyu, Can Ding, Richard W. Ziolkowski, and Y. Jay Guo. "A Terahertz (THz) Single-Polarization-Single-Mode (SPSM) Photonic Crystal Fiber (PCF)." Materials 12, no. 15 (July 31, 2019): 2442. http://dx.doi.org/10.3390/ma12152442.
Повний текст джерелаLee, Ji Eun, Myung Ah Lee, Tae Ho Hong, In Seok Lee, and Young Kyoung You. "Comparison of the efficacy between the gemcitabine/cisplatin (GP) and capecitabine/cisplatin (XP) for the advanced biliary tract cancer: Retrospective analysis in a single institution." Journal of Clinical Oncology 30, no. 4_suppl (February 1, 2012): 365. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.365.
Повний текст джерелаDe Braud, Filippo G., and Wentao Jason Wu. "A dose escalation pharmacokinetic (PK) and pharmacodynamic (PD) study of mTORC1/2 inhibitor XP-105 (BI 860585) as monotherapy and in combination with exemestane or paclitaxel in patients (pts) with advanced solid tumors." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 3127. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3127.
Повний текст джерелаBen Rekaya, Mariem, Nadia Laroussi, Olfa Messaoud, Mariem Jones, Manel Jerbi, Chokri Naouali, Yosra Bouyacoub, et al. "A Founder Large Deletion Mutation in Xeroderma Pigmentosum-Variant Form in Tunisia: Implication for Molecular Diagnosis and Therapy." BioMed Research International 2014 (2014): 1–8. http://dx.doi.org/10.1155/2014/256245.
Повний текст джерелаKrasikova, Yuliya, Nadejda Rechkunova, and Olga Lavrik. "Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities." International Journal of Molecular Sciences 22, no. 12 (June 9, 2021): 6220. http://dx.doi.org/10.3390/ijms22126220.
Повний текст джерелаPoddar, Rakshapada, Subhradeep Chakraborty, and Sudipta Chattopadhyay. "Improved Cross Polarization and Broad Impedance Bandwidth from Simple Single Element Shorted Rectangular Microstrip Patch: Theory and Experiment." Frequenz 70, no. 1-2 (January 1, 2016): 1–9. http://dx.doi.org/10.1515/freq-2015-0105.
Повний текст джерелаGarcía-García, J. I., D. Marín-Aragón, and A. Vigneron-Tenorio. "Union of Sets of Lengths of Numerical Semigroups." Mathematics 8, no. 10 (October 15, 2020): 1789. http://dx.doi.org/10.3390/math8101789.
Повний текст джерелаMulyantari, Kadek, Aryati ., and M. Y. Probohoesodo. "PENEMUAN (DETEKSI) ANTIBODI UNTUK ANTIGEN TUBERKULOSIS MENGGUNAKAN METODE IMUNOKROMATOGRAFI DI PENDERITA TUBERKULOSIS PARU." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 14, no. 3 (March 16, 2018): 127. http://dx.doi.org/10.24293/ijcpml.v14i3.938.
Повний текст джерелаKang, Y., W. K. Kang, D. B. Shin, J. Chen, J. Xiong, J. Wang, M. Lichinitser, M. Philco, T. Suarez, and J. Santamaria. "Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): LBA4018. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.lba4018.
Повний текст джерелаArmelini, Melissa G., Keronninn M. Lima-Bessa, Maria Carolina N. Marchetto, Alysson R. Muotri, Vanessa Chiganças, Ricardo A. Leite, Helotonio Carvalho, and Carlos F. M. Menck. "Exploring DNA damage responses in human cells with recombinant adenoviral vectors." Human & Experimental Toxicology 26, no. 11 (November 2007): 899–906. http://dx.doi.org/10.1177/0960327107083556.
Повний текст джерелаBeal Partyka, Raul, Jeferson Lana, and Rosilene Marcon. "A XP e o Itaú Unibanco: dos Produtos de Investimento a Desbancarização." Administração: Ensino e Pesquisa 21, no. 2 (May 1, 2020): 214–38. http://dx.doi.org/10.13058/raep.2020.v21n2.1749.
Повний текст джерелаDrouin, Réjean, Éric Lamiot, Kim Cantin, Sylvie F. Gauthier, Yves Pouliot, Patrice E. Poubelle, and Christina Juneau. "XP-828L (Dermylex), a new whey protein extract with potential benefit for mild to moderate psoriasisThis article is one of a selection of papers published in this special issue (part 1 of 2) on the Safety and Efficacy of Natural Health Products." Canadian Journal of Physiology and Pharmacology 85, no. 9 (September 2007): 943–51. http://dx.doi.org/10.1139/y07-084.
Повний текст джерелаTruckenbrodt, Hubert. "On the Relation between Syntactic Phrases and Phonological Phrases." Linguistic Inquiry 30, no. 2 (April 1999): 219–55. http://dx.doi.org/10.1162/002438999554048.
Повний текст джерелаOnishi, Masazumi, Kanako Tsunoda, Fumihiko Maeda, Shinichi Moriwaki, and Hiroo Amano. "Angiosarcoma of the Auricle in a Patient with Xeroderma Pigmentosum Variant." Case Reports in Dermatology 12, no. 2 (August 18, 2020): 144–49. http://dx.doi.org/10.1159/000508884.
Повний текст джерелаLueck, H., G. V. Minckwitz, A. Du Bois, I. Schrader, J. Huober, V. Heilmann, M. Beckmann, et al. "Epirubicin/paclitaxel (EP) vs. capecitabine/paclitaxel (XP) in first-line metastatic breast cancer (MBC): A prospective, randomized multicentre phase III study of the AGO breast cancer study group." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 517. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.517.
Повний текст джерела